Myles Minter
Stock Analyst at William Blair
(4.93)
# 178
Out of 4,429 analysts
544
Total ratings
58%
Success rate
32.2%
Average return
Main Sectors:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Reiterated: Hold | n/a | $63.96 | - | 26 | Jun 16, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | n/a | $15.67 | - | 17 | Jun 15, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | n/a | $1.51 | - | 14 | Jun 15, 2026 | |
| SLN Silence Therapeutics | Reiterated: Buy | n/a | $6.93 | - | 25 | Jun 11, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | n/a | $82.49 | - | 20 | Jun 10, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | n/a | $250.50 | - | 63 | Jun 4, 2026 | |
| ARGX argenx SE | Reiterated: Buy | n/a | $877.72 | - | 18 | Jun 4, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | n/a | $158.29 | - | 31 | Jun 2, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | n/a | $74.12 | - | 47 | May 28, 2026 | |
| BHVN Biohaven | Reiterated: Hold | n/a | $13.57 | - | 11 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $66.27 | - | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $196.58 | - | 29 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.31 | - | 13 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.53 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.64 | - | 18 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.99 | - | 11 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.20 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.74 | - | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.27 | - | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $52.91 | +52.43% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.6702 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.75 | - | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.13 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.10 | - | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $14 | $11.94 | +17.25% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $451.63 | - | 31 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $278.09 | - | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.12 | - | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.48 | n/a | 3 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.31 | n/a | 3 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $282.31 | n/a | 5 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.47 | n/a | 15 | Dec 29, 2022 |
Moderna
Jun 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $63.96
Upside: -
Intellia Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.67
Upside: -
Neumora Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.51
Upside: -
Silence Therapeutics
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.93
Upside: -
Dianthus Therapeutics
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $82.49
Upside: -
Axsome Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $250.50
Upside: -
argenx SE
Jun 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $877.72
Upside: -
Neurocrine Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $158.29
Upside: -
Ionis Pharmaceuticals
May 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.12
Upside: -
Biohaven
May 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.57
Upside: -
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $66.27
Upside: -
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $196.58
Upside: -
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $23.31
Upside: -
May 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.53
Upside: -
May 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.64
Upside: -
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $12.99
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.20
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.74
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.27
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $81
Current: $52.91
Upside: +52.43%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $0.6702
Upside: -
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.75
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.13
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $7.10
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $11.94
Upside: +17.25%
May 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $451.63
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $278.09
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: n/a
Current: $11.12
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $4.48
Upside: n/a
Sep 28, 2023
Maintained: Buy
Price Target: n/a
Current: $4.31
Upside: n/a
Mar 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $282.31
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $4.47
Upside: n/a